Contrast-Enhanced MRI Reveals Three Warning Signs of Poor Recovery in Brain Tuberculosis

Intracranial tuberculosis remains one of the most feared manifestations of Mycobacterium tuberculosis infection, striking the membranes, vessels, and parenchyma of the brain with consequences that can linger for a lifetime. Now, a retrospective study from Hangzhou Red Cross Hospital and The Second Affiliated Hospital of Zhejiang Chinese Medical University, published in BMC Infectious Diseases, offers clinicians a practical imaging-based framework for identifying which patients are most likely to face long-term disability or death. By systematically analyzing contrast-enhanced brain MRI scans and clinical records from 119 patients followed for more than a year, the research team identified three independent predictors of poor outcome: older age, acute cerebral infarction, and hydrocephalus.

The study’s design was straightforward but rigorous. The researchers collected clinical data and contrast-enhanced cranial MRI images from all patients admitted with intracranial tuberculosis between January 2018 and March 2026. Each patient underwent follow-up lasting at least 12 months, after which outcomes were graded using the modified Rankin Scale, a standard clinical measure of functional disability. Patients scoring 0 to 2, meaning little to no disability, formed the favorable prognosis group of 67 individuals, while those scoring 3 to 6, ranging from moderate disability to death, formed the poor prognosis group of 52 patients.

Contrast-enhanced MRI was central to the investigation because it reveals pathological changes that plain CT and non-contrast imaging often miss. Gadolinium-based contrast agents leak across disrupted blood-brain barriers, highlighting thickened, inflamed meninges, tuberculomas, abscesses, and the characteristic basal enhancement pattern of tuberculous meningitis. This technique allowed the team to classify patients into imaging subtypes and to document complications such as cerebral infarction, hydrocephalus, and cerebral arteritis with far greater sensitivity than conventional approaches.

When the two prognosis groups were compared, striking differences emerged. Patients in the poor prognosis group were older and more frequently male. They more often presented with meningeal-type or mixed-type intracranial tuberculosis rather than the parenchymal form, and they showed significantly higher rates of meningeal thickening, involvement of the basal and pericallosal cisterns, multi-site meningeal involvement, acute cerebral infarction, hydrocephalus, and cerebral arteritis. Conversely, parenchymal-type disease and tuberculomas were less common in the poor outcome group, suggesting that disease confined to brain tissue with discrete granulomas may carry a better outlook than diffuse meningeal inflammation.

To move beyond simple associations, the researchers performed multivariate logistic regression, a statistical technique that isolates the independent contribution of each variable while controlling for all others. Three factors emerged as independent risk factors for poor long-term prognosis: age, acute cerebral infarction, and hydrocephalus. This finding is clinically meaningful because it separates true prognostic drivers from markers that merely travel alongside them. Meningeal thickening and arteritis, for example, were more common in poor-outcome patients but did not retain independent predictive value once infarction and hydrocephalus were accounted for.

The predictive model built from these three variables performed impressively well. Evaluated with receiver operating characteristic analysis, it achieved an area under the curve of 0.861, sensitivity of 70.1 percent, specificity of 89.6 percent, and overall accuracy of 80.7 percent. In practical terms, the model correctly identified nearly nine out of ten patients who would ultimately do well, while capturing seven out of ten of those destined for poor outcomes. An AUC above 0.85 is generally considered strong discrimination for a clinical prediction model, particularly one built on routinely available imaging and demographic data.

Each of the three predictors tells a coherent biological story. Older patients have less physiological reserve, more comorbidities, and blunted immune responses that impair clearance of infection and repair of tissue damage. Acute cerebral infarction in tuberculous meningitis typically results from inflammatory occlusion of small perforating arteries at the base of the brain, where exudate accumulates in the subarachnoid space and triggers vasculitis. Once brain tissue is lost to infarction, recovery is limited, and the infarct itself serves as a proxy for both disease severity and vascular involvement. Hydrocephalus, meanwhile, arises when inflammatory debris obstructs cerebrospinal fluid flow through the ventricular system or impairs its resorption at the arachnoid granulations, raising intracranial pressure and compressing neural tissue.

The Evans index, a ratio comparing the width of the frontal horns of the lateral ventricles to the maximal internal diameter of the skull, was among the imaging variables recorded, providing a quantitative measure of ventricular enlargement. Its inclusion alongside direct assessments of hydrocephalus reflects the study’s effort to capture both qualitative radiological judgments and reproducible morphometric markers. Similarly, the initial Glasgow Coma Scale score was documented for each patient, anchoring the clinical assessment at admission and allowing the investigators to account for baseline neurological status.

The implications for clinical practice are substantial. Patients with intracranial tuberculosis who present with advanced age, evidence of acute infarction on contrast-enhanced MRI, or ventricular enlargement can now be flagged early as high risk, prompting intensified monitoring, earlier consideration of surgical intervention for hydrocephalus such as ventriculoperitoneal shunting, and closer attention to antitubercular therapy optimization. Conversely, patients with parenchymal-type disease and tuberculomas, who showed more favorable outcomes in this cohort, may be candidates for less intensive follow-up protocols, though the authors caution that individualized assessment remains essential.

Limitations of the study are worth noting. As a single-center retrospective analysis, its findings require validation in larger, multicenter cohorts before widespread adoption of the risk model. The retrospective design also means that imaging protocols and clinical management may have varied over the eight-year enrollment period. Nevertheless, the study demonstrates that contrast-enhanced cranial MRI, already a mainstay of diagnosis in intracranial tuberculosis, can be repurposed as a prognostic tool, transforming a routine diagnostic scan into a roadmap for risk stratification and early intervention. As tuberculosis continues to pose a global burden, particularly in regions with limited neurosurgical resources, simple imaging-based predictors of outcome could help clinicians allocate intensive care where it matters most.

Subject of Research: Risk stratification of intracranial tuberculosis patients using contrast-enhanced MRI predictors of long-term prognosis

Article Title: Risk stratification in intracranial tuberculosis patients based on contrast-enhanced MRI

Article References: Wang, Y.-J., Qiu, X.-W., Wang, A.-L., Hu, Y.-N., Li, W.-Q., & Huang, X.-S. (2026). Risk stratification in intracranial tuberculosis patients based on contrast-enhanced MRI. BMC Infectious Diseases. https://doi.org/10.1186/s12879-026-14479-w

Image Credits: AI Generated

DOI: 10.1186/s12879-026-14479-w

Keywords: intracranial tuberculosis, contrast-enhanced MRI, hydrocephalus, cerebral infarction, tuberculous meningitis, prognosis, risk stratification, neuroradiology, modified Rankin Scale, cerebral arteritis, BMC Infectious Diseases, Risk